Company Registration No. SC665433 (Scotland)
DOW DRUG DEVELOPMENT SOLUTIONS LIMITED
Annual Report and Statement of Accounts
For the Period from 01 July 2025 to 30 June 2026

DOW DRUG DEVELOPMENT SOLUTIONS LIMITED

Annual report and statement of accounts for the period ending 30/06/2026

DOW DRUG DEVELOPMENT SOLUTIONS LIMITED

Financial statement for the period ended 30/06/2026

Company Information

1 Statutory Information
Company Number SC665433
Registered Office 1 CRAIGLOCKHART PARK
EDINBURGH
EH14 1ER
2 Directors
Directors who held office during the period were:
Margaret Sara DOW   
Robert James DOW   
3 Principal Activity
The principal activity of the company is providing consulting services to the drug industry.
4 Employees
Average number of employees, including directors, during the year was as follows:
2026 2
2025 2

DOW DRUG DEVELOPMENT SOLUTIONS LIMITED

Financial statement for the period ended 30/06/2026

Statement of Financial Position

2026 2025
£ £
Fixed Assets 548 1,489
Current Assets 61,118 80,760
Creditors: amounts falling due within one year (7,301) (14,479)
Net Current Assets 53,817 66,281
Total assets less current liabilities 54,365 67,770
Creditors: amounts falling due after one year - -
Net Assets 54,365 67,770
Capital and reserves 54,365 67,770
For the period ending 30/06/2026 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
Approved by the Board on 15 October 2026
Sara Margaret Dow
Company Registration No. SC665433